AtriCure, Inc.
ATRC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,435,250 | $1,652,768 | $2,029,941 | $3,133,439 |
| - Cash | $122,721 | $84,310 | $58,099 | $43,654 |
| + Debt | $76,530 | $74,494 | $74,548 | $75,647 |
| Enterprise Value | $1,389,059 | $1,642,952 | $2,046,390 | $3,165,432 |
| Revenue | $465,307 | $399,245 | $330,379 | $274,329 |
| % Growth | 16.5% | 20.8% | 20.4% | – |
| Gross Profit | $347,524 | $300,370 | $245,940 | $205,860 |
| % Margin | 74.7% | 75.2% | 74.4% | 75% |
| EBITDA | -$18,534 | -$8,109 | -$29,502 | $65,746 |
| % Margin | -4% | -2% | -8.9% | 24% |
| Net Income | -$44,698 | -$30,438 | -$46,466 | $50,199 |
| % Margin | -9.6% | -7.6% | -14.1% | 18.3% |
| EPS Diluted | -0.95 | -0.66 | -1.02 | 1.09 |
| % Growth | -43.9% | 35.3% | -193.6% | – |
| Operating Cash Flow | $12,204 | $4,484 | -$22,141 | -$13,780 |
| Capital Expenditures | -$23,459 | -$41,998 | -$16,881 | -$9,753 |
| Free Cash Flow | -$11,255 | -$37,514 | -$39,022 | -$23,533 |